Despite these constraints, the study has several strengths: to our knowledge, it is the first to assess the independent and joint associations of ANGPTL4 with glycemic status and hepatic steatosis, and it enrolled a larger sample than prior investigations. Here, ANGPTL4 is linked to fatty liver disease.